Heritable Human Genome Editing Is Not Inevitable
By Donna Dickenson, Katie Hasson & Marcy Darnovsky,
Project Syndicate
| 03. 17. 2020
In recent years, the consensus barring genetic changes that would be passed down to a person’s every descendant has collapsed, and scientists and bioethicists now focus largely on creating a detailed roadmap for moving forward. But there's a strong case to be made that the previous consensus was correct.
The announcement by the Chinese biophysicist He Jiankui in November 2018 that he had created the world’s first gene-edited babies – an egregious ethical and legal breach that resulted in a three-year prison sentence – gave discussions about heritable human genome editing a new sense of urgency. But those discussions are fundamentally flawed. Given the stakes – for today’s societies and future generations – a course correction is urgently needed.
Some scientists, futurists, and others assert the inevitability of heritable genome editing – altering embryos or gametes in order to produce genetically engineered children who will pass the changed genes and traits to their own offspring. These proponents seem to assume that, overall, it would probably be a good thing – as long as we wait until the technology is “safe” and apply it under the right circumstances. With this in mind, they have focused largely on creating a detailed roadmap for moving forward.
The organizers of the 2018 International Summit on Human Gene Editing, held just days after He’s announcement, proclaimed that “it is time to define a rigorous...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...